HIV infection – Diagnostics – Overview of Information and Clinical Research

Detecting HIV infection early is a crucial step in managing this chronic condition effectively. Testing is straightforward, widely available, and empowers individuals to take control of their health, whether that means starting treatment to live a long, healthy life or accessing preventive measures to protect themselves and others.

Who Should Get Tested and When

Everyone between the ages of 13 and 64 should get tested for HIV at least once in their lifetime. This recommendation exists because HIV can hide in the body for years without causing noticeable symptoms, meaning many people who have the virus don’t know they’re infected. Without testing, the infection can silently damage the immune system while potentially being passed to others unknowingly.^[1]

Some people need to get tested more frequently than once. If you’re sexually active and have multiple partners, if you’ve had unprotected sex with someone whose HIV status you don’t know, or if you share needles or drug injection equipment, regular testing becomes especially important. Men who have sex with men, people who exchange sex for money or other items, and anyone who has been diagnosed with another sexually transmitted infection should also consider more frequent testing.^[5]

You should seek testing immediately if you think you’ve been exposed to the virus in the last 72 hours. This could include situations like having unprotected sex with someone who might have HIV, sharing needles, or being sexually assaulted. In these cases, emergency medicine called post-exposure prophylaxis, or PEP, may be available to prevent infection, but it must be started quickly.^[8]

Pregnant women or those considering pregnancy should definitely get tested. If HIV is detected early, treatment during pregnancy can protect the baby from getting infected during pregnancy, birth, or breastfeeding. Anyone with a current or previous partner who has HIV, people from countries with high HIV rates, or those who have received blood transfusions in countries without effective HIV screening should also prioritize testing.^[8]

Testing is especially advisable if you develop certain symptoms. Some people experience flu-like symptoms within 2 to 4 weeks after infection, including fever, sore throat, headache, muscle aches, swollen lymph glands, rash, and tiredness. However, these symptoms can also be caused by many common conditions, and some people with HIV have no symptoms at all during early infection. That’s why relying on symptoms alone is never enough—only testing can confirm your status.^[1]^[3]

⚠️ Important

The only way to know if you have HIV is to get tested. You cannot tell by looking at someone whether they have HIV, and you cannot rely on symptoms alone since many people with HIV feel perfectly healthy for years while the virus is present in their body.^[1]^[9]

Classic Diagnostic Methods for HIV

HIV testing uses either blood or saliva samples to detect the presence of the virus or the body’s response to it. There are several types of tests, each looking for different markers of infection and becoming accurate at different times after exposure.^[11]

Antigen-Antibody Tests

The most commonly used tests are called antigen-antibody tests. These look for two things at once in your blood. First, they search for antigens, which are substances that are part of the HIV virus itself. Antigens typically show up in the blood within a few weeks after someone is exposed to HIV. Second, these tests look for antibodies, which are proteins your immune system creates when it detects the virus trying to fight it off. Antibodies can take weeks to months to appear.^[11]

Antigen-antibody tests usually use blood drawn from a vein in your arm. They’re highly accurate but require a waiting period called a window period—the time between potential exposure and when the test can reliably detect infection. For antigen-antibody tests, you may not show a positive result until 2 to 6 weeks after exposure. During this window period, a person can still have HIV and pass it to others even though the test shows negative.^[11]

Antibody Tests

Another type of test looks only for antibodies to HIV in your blood or saliva. Most rapid HIV tests, including those you can do at home, are antibody tests. These tests are convenient and can provide results in as little as 20 minutes. However, they have a longer window period than antigen-antibody tests—you may not show a positive result until 3 to 12 weeks after you’ve been exposed to HIV.^[11]

Rapid tests are particularly useful because they’re quick, painless, and often free at community health centers, sexual health clinics, and other testing sites. However, if you get a positive result from a rapid test, you’ll need a follow-up test to confirm the diagnosis. If you get a negative result but were recently exposed to HIV, you may need to be tested again after the window period has passed.^[1]

Nucleic Acid Tests

Nucleic acid tests, or NATs, are different from the other two types because they look directly for the virus itself in your blood, measuring what’s called the viral load. These tests use blood drawn from a vein and are the most expensive type of HIV test. However, they have the shortest window period and can detect HIV earlier than other tests—sometimes as soon as 10 to 33 days after exposure.^[11]

NATs aren’t used for routine screening because of their cost. They’re typically recommended when someone might have been exposed to HIV very recently, such as healthcare workers who’ve had a needle stick injury, or when someone develops symptoms consistent with early HIV infection. Because they can detect the virus so early, they’re valuable in situations where knowing the status quickly is critical.^[11]

Follow-up and Confirmatory Testing

If your initial test comes back positive, additional testing is always done to confirm the result. This is standard practice to make sure the diagnosis is accurate before you begin any treatment. Your healthcare provider will discuss the results with you and may order additional blood tests to understand more about your infection, including how much virus is in your blood and how your immune system is functioning.^[11]

Testing negative doesn’t necessarily mean you’re free from HIV if you were recently exposed. Your healthcare provider may recommend follow-up testing weeks or months later to account for the window period. This is particularly important if you continue to engage in activities that put you at risk for HIV infection.^[11]

Tests Used for Treatment Monitoring and Clinical Trial Qualification

Once someone is diagnosed with HIV, additional tests become important for monitoring the infection and determining the best treatment approach. These same tests are often used as criteria for enrolling patients in clinical trials studying new HIV treatments or prevention methods.

CD4 T Cell Count

One of the most important tests measures the number of CD4 T cells, also called CD4 cells or helper T cells, in your blood. These are white blood cells that HIV attacks and destroys. Your CD4 count tells doctors how much damage HIV has done to your immune system. A healthy person typically has between 500 and 1,600 CD4 cells per cubic millimeter of blood. When HIV infection progresses without treatment, these numbers drop.^[11]

CD4 counts help doctors understand the stage of HIV infection and decide when to start certain preventive treatments for infections that take advantage of a weakened immune system. When CD4 counts drop very low—below 200 cells per cubic millimeter—or when certain serious infections or cancers develop, the person is diagnosed with AIDS, the most advanced stage of HIV infection.^[2]^[11]

For clinical trials, CD4 counts are often used as enrollment criteria. Some studies may require participants to have CD4 counts above or below certain thresholds, depending on what the trial is testing. Regular CD4 monitoring during the trial also helps researchers understand how well an experimental treatment is working.^[11]

Viral Load Testing

Viral load tests measure how much HIV is in your blood. The results are reported as the number of copies of the virus per milliliter of blood. A high viral load means there’s a lot of virus present, while a low viral load means there’s less. When someone takes HIV treatment as prescribed, the goal is to reduce the viral load to undetectable levels—so low that standard tests can’t find the virus.^[1]^[11]

Having an undetectable viral load is extremely important. It means the person’s immune system can recover and they can stay healthy. Perhaps most significantly, people with undetectable viral loads cannot transmit HIV to their sexual partners—a principle known as “undetectable equals untransmittable” or U=U. Viral load testing is repeated regularly to make sure treatment continues to work effectively.^[1]

Clinical trials almost always use viral load as a key measure of success. Studies testing new HIV medications want to see how well those drugs can reduce viral load and keep it suppressed over time. Trials may require participants to have certain viral load levels at enrollment, and viral load is checked frequently throughout the study to track progress.^[11]

Drug Resistance Testing

Sometimes HIV can develop resistance to certain medications, meaning those drugs stop working effectively. Drug resistance testing analyzes the genetic makeup of the virus in someone’s blood to see if it has mutations that make it resistant to specific HIV medicines. This information helps doctors choose the right combination of drugs that will work for that particular person.^[11]

Drug resistance testing is typically done when someone is first diagnosed with HIV, before starting treatment, and again if their treatment stops working as well as it should. For clinical trials, understanding drug resistance patterns helps researchers determine who can participate in studies testing particular medications and helps explain why some treatments work better than others in different people.^[11]

⚠️ Important

Getting tested regularly and starting treatment early gives you the best chance of living a long, healthy life with HIV. Modern HIV treatment is so effective that most people who take their medicines as prescribed can achieve an undetectable viral load within six months and live a normal lifespan while protecting their partners from infection.^[12]

Additional Laboratory Tests

People with HIV need various other blood tests to monitor their overall health and watch for side effects from medications. These can include tests to check liver and kidney function, cholesterol levels, blood sugar levels, and screening for other infections like hepatitis B and C, tuberculosis, and sexually transmitted infections. These tests help ensure that HIV treatment is working safely and that any other health issues are caught and treated early.^[11]

Clinical trials often include these comprehensive laboratory panels as part of their screening and monitoring processes. Researchers need to ensure participants are healthy enough to safely receive experimental treatments and to detect any harmful effects that might occur during the study. The frequency and type of testing in clinical trials is usually more intensive than in routine care, providing detailed information about how new treatments affect the body.^[11]

Prognosis and Survival Rate

Prognosis

With modern treatment, the prognosis for people living with HIV has improved dramatically. HIV is now considered a manageable chronic condition rather than a fatal disease. People with HIV who start treatment early and take their medications consistently can live long, healthy lives with a near-normal life expectancy. The key factors affecting prognosis include how quickly the infection is detected, how soon treatment begins, how well someone follows their treatment plan, and their overall health status.^[1]^[2]

Without treatment, HIV typically progresses to AIDS in about 10 years, though this timeline varies among individuals. However, with effective antiretroviral therapy, most people in developed countries with access to treatment do not develop AIDS. Treatment works by reducing the amount of virus in the body, allowing the immune system to recover and maintain its ability to fight infections. When people achieve and maintain an undetectable viral load, they not only protect their own health but also cannot transmit the virus to others through sexual contact.^[5]^[14]

Factors that can affect prognosis include whether someone has other health conditions, develops drug resistance to HIV medications, experiences significant medication side effects, or has difficulty accessing consistent healthcare. Social and economic factors, mental health, substance use, and support systems also play important roles in long-term outcomes. Regular medical monitoring through CD4 counts and viral load tests helps healthcare providers adjust treatment as needed to ensure the best possible outcomes.^[7]

Survival rate

Thanks to effective antiretroviral therapy, people with HIV in developed countries who receive proper treatment can now expect to live nearly as long as people without HIV. When treatment is started early and taken consistently, life expectancy can be close to normal. The transformation in survival rates has been remarkable—what was once a fatal diagnosis has become a manageable chronic condition for most people with access to modern care.^[1]^[2]

The global HIV pandemic has claimed approximately 40.4 million lives since it was first identified in 1983, including 1.5 million children. However, mortality rates have steadily decreased as antiretroviral therapy has become more widely available and more effective. Current goals set by health organizations aim to ensure that by 2025, 95% of people with HIV are diagnosed, 95% of those diagnosed receive treatment, and 95% of those on treatment achieve viral suppression—a target that would dramatically reduce HIV-related deaths worldwide.^[7]